HL151

DRUG4 trials

Sponsors

Hanlim Pharm. Co., Ltd.

Conditions

Perennial Allergic RhinitisPruritusRhinitis, Allergic, Perennial

Phase 1

Single Dosing Clinical Trial of HL151

CompletedNCT02682745

Hanlim Pharm. Co., Ltd.Rhinitis, Allergic, Perennial

Start: 2016-01-15End: 2016-02-12Updated: 2018-08-17

Repeated Dosing Clinical Trial of HL151

CompletedNCT02686294

Hanlim Pharm. Co., Ltd.Rhinitis, Allergic, Perennial

Start: 2016-02-16End: 2016-03-15Updated: 2018-08-17

Phase 3

Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus

CompletedNCT03317301

Hanlim Pharm. Co., Ltd.Pruritus

Start: 2017-05-17End: 2018-01-30Updated: 2018-08-28

To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients

CompletedNCT03655210

Hanlim Pharm. Co., Ltd.Perennial Allergic Rhinitis

Start: 2017-02-07End: 2017-10-16Updated: 2018-08-31